Welcome to our dedicated page for Acadia Healthcar news (Ticker: ACHC), a resource for investors and traders seeking the latest updates and insights on Acadia Healthcar stock.
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) is a behavioral healthcare company that operates a large network of inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, comprehensive treatment centers and outpatient clinics across the United States and Puerto Rico. This news page aggregates company-specific updates and disclosures that help investors and observers follow developments in Acadia’s behavioral healthcare operations and corporate activities.
News related to ACHC often includes quarterly earnings releases, updates to financial guidance, and details on revenue performance by service type, such as acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers and residential treatment centers. The company also issues news about capital expenditure plans, bed additions, and development activity, including the opening of new hospitals, expansions of existing facilities and the addition of new comprehensive treatment centers.
Acadia’s news flow features announcements about participation in healthcare and investor conferences hosted by firms such as J.P. Morgan, UBS and Jefferies, where members of senior management discuss strategy, capital allocation and operating performance. Press releases may also cover executive leadership changes, including appointments and transitions in key roles like the Chief Financial Officer and Chief Operating Officer, as well as statements from the company regarding its approach to shareholder value and governance.
Other notable news items can include updates on professional and general liability reserves, securities litigation settlements, and responses to public letters from shareholders who comment on strategy and governance. By reviewing the ACHC news feed on this page, users can monitor Acadia’s reported operating trends, strategic priorities, capital plans and governance developments over time.
Acadia Healthcare (NASDAQ: ACHC) reported Q1 2026 revenue of $828.8 million, up 7.6% year-over-year, and Adjusted EBITDA of $144.2 million. The company raised full-year 2026 Adjusted EBITDA and Adjusted EPS guidance, now targeting $580–$615 million Adjusted EBITDA and $1.35–$1.60 Adjusted EPS.
Q1 results included same-facility revenue +7.3%, added 82 licensed beds, cash of $158.5 million, and net leverage of 3.9x Adjusted EBITDA as of March 31, 2026.
National Veterinary Associates (ACHC) named Todd S. Young as Chief Financial Officer, effective May 1, 2026. He will report to CEO John Bruno and join the executive leadership team. Young brings more than 25 years in human and animal healthcare finance, including prior CFO roles at Acadia Healthcare (NASDAQ: ACHC) and Elanco (NYSE: ELAN).
Young said he looks forward to strengthening NVA's financial foundation as the company continues investing across its care network.
Acadia Healthcare (NASDAQ: ACHC) appointed David Duckworth as Interim Chief Financial Officer effective May 1, 2026, succeeding Todd Young, who will remain through April 30, 2026. The interim assignment will last at least until the completion of the ongoing CEO search.
The company reaffirms Q1 2026 guidance of revenue $820–$830 million, adjusted EBITDA $130–$137 million, adjusted EPS $0.25–$0.30, and full‑year 2026 guidance of revenue $3.37–$3.45 billion, adjusted EBITDA $575–$610 million, adjusted EPS $1.30–$1.55. Q1 results will be issued April 29; earnings call on April 30 at 9:00 a.m. ET.
Acadia Healthcare (NASDAQ: ACHC) will release its first quarter 2026 results on Wednesday, April 29, 2026, after market close. The company will host a conference call for institutional investors and analysts on Thursday, April 30, 2026 at 9:00 a.m. ET.
A live webcast will be available in Acadia's Investors section and the replay will remain accessible for 30 days.
Acadia Healthcare (NASDAQ: ACHC) appointed Daniel Cancelmi to its Board of Directors effective March 12, 2026, and announced director Wade D. Miquelon will not stand for re-election at the 2026 Annual Meeting. Cancelmi brings three decades of healthcare finance experience, most recently as CFO of Tenet Healthcare. The Board selection followed a search and engagement with Khrom Capital. Goldman Sachs and J.P. Morgan are financial advisors; Kirkland & Ellis is legal advisor.
Acadia Healthcare (NASDAQ: ACHC) reported Q4 2025 revenue of $821.5M (up 6.1% YoY) and full-year 2025 revenue of $3.313B (up 5.0%). The company recorded a non-cash $996.2M goodwill impairment, producing a GAAP net loss per diluted share of $13.02 for Q4.
Acadia posted Q4 Adjusted EBITDA of $99.8M and provided 2026 guidance: revenue $3.37–3.45B, Adjusted EBITDA $575–610M, and adjusted EPS $1.30–1.55.
Acadia Healthcare (NASDAQ: ACHC) will participate in three investor conferences in March 2026 with scheduled presentations and live webcasts. Presentations: Raymond James on March 2 at 11:35 a.m. ET, Leerink on March 9 at 3:40 p.m. ET, and Barclays on March 10 at 12:00 p.m. ET.
A live webcast and a replay available for 30 days will be accessible via the company website under the Investors section.
Acadia Healthcare (NASDAQ: ACHC) will release its fourth quarter and year-end 2025 results on Wednesday, February 25, 2026, before the market opens.
The company will host a conference call with institutional investors and analysts on February 25, 2026 at 9:00 a.m. ET, with a live webcast available on the company’s Investors page and a replay for 30 days.
Acadia Healthcare (NASDAQ: ACHC) appointed Debra K. Osteen as Chief Executive Officer and added her to the Board, effective immediately, with Chris Hunter departing the company and its Board. The Board said it will conduct a comprehensive search for a long-term successor while Osteen leads the company. The company reaffirms its full-year 2025 guidance, expecting revenue $3.28B–$3.30B, Adjusted EBITDA $601M–$611M, and adjusted EPS $1.94–$2.04. Management previously reiterated guidance at the J.P. Morgan Healthcare Conference on January 13, 2026. The company noted it cannot reconcile projected Adjusted EBITDA and adjusted EPS to GAAP due to unknown transaction-related expenses and their tax effects.
Acadia Healthcare (NASDAQ: ACHC) will participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, January 12-15, 2026. The company’s presentation is scheduled for Tuesday, January 13, 2026 at 5:15 p.m. PT / 7:15 p.m. CT and will be webcast live on Acadia’s investor website.
A replay will be available on the company website for 30 days following the presentation. Investors can access the live webcast via the Investors section at www.acadiahealthcare.com.